Search NLS News

Researchers at Karolinska Institutet and the University of Innsbruck have developed a simpler and more effective screening method for cervical cancer than the method used today they state. A comprehensive study published in Nature Medicine shows that the test detects significantly more cancers and precancerous stages. Most countries have a very extensive screening program that […]

How one of the largest health care providers in the U.S. leverages Vaisala humidity and temperature instruments to meet strict accreditation standards for safe operating room and laboratory environments. One of the most significant U.S. health care systems is harnessing the power of measurement technology to help patients feel whole and deliver compassionate, world-class care. […]

San Diego, June 4th, 2024. At 8.30 in the morning, Swedish delegates at BIO 2024 were greeted by SwedenBIO’s Jessica Martinsson and Frida Eriksson, as they walked into the breakfast room at Malibu Farm, a restaurant overlooking the Pacific Ocean. Located only a few hundred meters from the huge conference center, this was a perfect […]

Umeå is strengthening its position as a life science hub thanks to two regional development projects receiving around EUR 1.8 million (SEK 22 million) in EU support. These projects aim to boost innovation, collaboration, and industry growth. “This presents an opportunity to further elevate Umeå’s standing as a life science leader,” saysPeter Jacobsson, Operations Coordinator […]

The LifeFactFuture consortium includes the University of Turku, the University of Helsinki, Orion, some of Finland’s leading life science manufacturers, and data and technology companies. The project, led by the University of Turku and for which Business Finland recently granted EUR 11.7 million funding, seeks to enhance advanced pharmaceutical and life science manufacturing in Finland. […]

Ilya Pharma has announced that its preclinical data for ILP100 in an oral formulation have been published in American Journal pf Physiology, Gastrointestinal and Liver Physiology. ILP100-Oral, the company’s investigational immunotherapy is being developed as first-line-treatment for patients with immune mediated enterocolitis resulting from cancer treatment with checkpoint inhibitors. This is the indication where local treatment […]

The two companies have announced a strategic partnership to use Shinobi’s immune evasive iPS-T cell platform with novel candidate TCRs, discovered and validated by Anocca, to develop a new class of off-the-shelf allogeneic TCR engineered iPS-T-cell therapies (TCR-iPS-T) for solid tumors. “As we prepare to progress our first gene-edited autologous TCR-T product into the clinic, […]

The status of national strategies and a common Nordic roadmap. Rare disease companies struggle with a range of challenges, one of which is how to balance funding R&D with a small market size. Healthcare systems and societies also face a balancing act when it comes to rare diseases – between innovation and accessibility. Having a […]

It’s an exciting time to be a part of Norway’s health and life science environment, with a marked uptick in activity and a distinct sense of progress brewing.

Asahi Kasei Corp has announced that it will offer the shareholders of Calliditas Therapeutics to acquire the shares of the pharmaceutical company Calliditas for the purpose of making Calliditas a wholly-owned subsidiary of Asahi Kasei through a voluntary tender offer for Calliditas. In the Board’s opinion, the combination of Asahi Kasei and Calliditas will leverage […]